Compound name
Margetuximab
Compound Image
Margetuximab.png
Approval Jurisdiction
2020 FDA
Approved for clinical use
MHER2-Positive Breast Cancer
CAS
1350624-75-7
Action
HER2
Approved Drug List
1
Commercial Vendor
Raven Biotech
Reference
Reference 2